About Brian Park, MD, MPH

Dr. Brian Park is a head and neck surgeon and otolaryngologist based at our Newton and Wellesley locations. Board-certified in otolaryngology, Dr. Park treats adult patients with general otolaryngology disorders and has a specialization in community-based head and neck oncology. He is a member of the American Head and Neck Society and a fellow of the American College of Surgeons. Dr. Park has published a number of peer-reviewed articles in the field.

Dr. Park’s clinical interests include head and neck surgery, salivary gland surgery and nasal surgery.

Departments, Centers, & Programs:

Clinical Interests:



Mass Eye and Ear at Wellesley
65 Walnut St.
Suite 590
Wellesley, MA 02481
Phone: 617-630-1699

Mass Eye and Ear at Newton
2000 Washington St.
Suite 668
Newton, MA 02462
Phone: 617-630-1699

Medical Education

  • MPH, Boston University School of Public Health
  • MD, SUNY at Syracuse (Upstate) College of Medicine
  • Residency, SUNY Upstate Medical University Hospital
  • Fellowship, Univ. of Pittsburgh Med. Ctr.

American Board Certifications

  • Otolaryngology-Head and Neck Surgery, American Board of Otolaryngology


  • Park BJ, Chiosea SI, Grandis JR. "Molecular Changes in the Multistage Pathogenesis of Head and Neck Cancer."  Molecular Pathology of Early Cancer.  2nd edition.  Eds. Grizzle, Srivastava, & van der Sluijs.  Amsterdam: IOS Press, currently in press.

    Park BJ, Kalish RJ, Vercillo AP.  Disseminated Plasmacytoma of the Thyroid.  Ear Nose Throat Journal 89(3):137-9, 2010 Mar.

    Davidson HC, Park BJ, Johnson JT.  Thyroid Cancer: Controversies in the Management of Neck Metastasis.  Laryngoscope. 118(12):2161-5, 2008 Dec.

    Park BJ, Tatum SA.  Oculoauriculovertebral Spectrum in Two Siblings.  International Journal of Pediatric Otorhinolaryngology Extra 2 (3): 161-164, 2007.

    Park B, Nguyen NT, Dutt P, Merdek KD, Bashar M, Sterpetti P, Tosolini A, Testa JR, Toksoz D. Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation. Journal of Biological Chemistry. 277(47):45361-70, 2002 Nov 22.

    Sterpetti P, Hack AA, Bashar MP, Park B, Cheng SD, Knoll JH, Urano T, Feig LA, Toksoz D. Activation of the Lbc Rho exchange factor proto-oncogene by truncation of an extended C terminus that regulates transformation and targeting. Molecular & Cellular Biology. 19(2):1334-45, 1999 Feb.

Reviews: Comments and Ratings